Company intelligence / Profile preview

Laser Technology

Ownership: Private
Development stage: Commercial

Overview

Laser Biotech International markets FDA-cleared Class 3b and Class 4 superpulsed lasers under the Lumix brand. These devices are used by clinicians for pain relief, inflammation reduction, and tissue healing. The technology is featured in published research demonstrating therapeutic ability to regenerate tissue and promote healing[1].

Therapeutic areas: OtherDermatologyImmunologyNeurology
Modalities: Device (therapeutic laser)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Laser Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laser Technology.

Explore the full profile